[[{“value”:”
### Dana-Farber Cancer Institute Wins Approval for New Hospital
The Massachusetts Public Health Council has unanimously approved a Determination of Need for Dana-Farber Cancer Institute to construct a 300-bed cancer hospital in the Longwood Medical Area. This new facility, reportedly the only one of its kind in the region, will serve as the central hub for clinical collaboration between Dana-Farber, Beth Israel Deaconess Medical Center, and Harvard Medical Faculty Physicians.
Originally announced in September 2023, Dana-Farber estimates the project will cost $1.68 billion. The hospital will be built on the current site of the Joslin Diabetes Center along Brookline Avenue, adjacent to both Beth Israel Deaconess and Dana-Farber Cancer Institute.
“This is an extraordinary opportunity for Boston and the Commonwealth,” said Dana-Farber president and CEO Benjamin L. Ebert, MD, PhD. “While the incidence of cancer is rising, what we do now will determine our ability to meet the pace of the disease here and across the region.”
“}]]
